9
| Company | Price & Valuation | My FV & Narrative | Valuation | Growth | Analyst Target | |
|---|---|---|---|---|---|---|
DRO DroneShield AU$3.7816.0% undervalued intrinsic discount 4.7%7D -9.6%3M | ||||||
IREN IREN US$50.6447.1% undervalued intrinsic discount 3.9%7D -15.6%3M | ||||||
DUOL Duolingo US$103.4524.0% undervalued intrinsic discount -1.3%7D -29.2%3M | ||||||
GQG GQG Partners AU$1.6335.4% overvalued intrinsic discount -5.0%7D 2.5%3M | ||||||
AMTM Amentum Holdings US$25.8522.7% undervalued intrinsic discount -6.4%7D -26.9%3M | ||||||
GANX Gain Therapeutics US$1.9774.1% undervalued intrinsic discount -7.1%7D -4.4%3M | ||||||
GRAB Grab Holdings US$3.9012.2% undervalued intrinsic discount -7.4%7D -16.8%3M | ||||||
FIG Figma US$17.477.0% undervalued intrinsic discount -8.1%7D -38.6%3M | ||||||
FBR FBR AU$0.00397.0% undervalued intrinsic discount -25.0%7D -25.0%3M |
9
| Company | Price & Valuation | My FV & Narrative | Valuation | Growth | Analyst Target | |
|---|---|---|---|---|---|---|
DRO DroneShield 4.7%7D -9.6%3M | AU$3.78 16.0% undervalued intrinsic discount | PS 16.1x | E 61.0% | AU$4.40 | ||
IREN IREN 3.9%7D -15.6%3M | US$50.64 47.1% undervalued intrinsic discount | PE 43.2x | E -40.8% | US$72.07 | ||
DUOL Duolingo -1.3%7D -29.2%3M | US$103.45 24.0% undervalued intrinsic discount | PE 11.7x | E -32.5% | US$104.97 | ||
GQG GQG Partners -5.0%7D 2.5%3M | AU$1.63 35.4% overvalued intrinsic discount | PE 7.5x | E -3.5% | AU$1.90 | ||
AMTM Amentum Holdings -6.4%7D -26.9%3M | US$25.85 22.7% undervalued intrinsic discount | PE 64.3x | E 30.8% | US$36.55 | ||
GANX Gain Therapeutics -7.1%7D -4.4%3M | US$1.97 74.1% undervalued intrinsic discount | PB 4.5x | E 30.1% | US$7.60 | ||
GRAB Grab Holdings -7.4%7D -16.8%3M | US$3.90 12.2% undervalued intrinsic discount | PE 59.7x | E 25.1% | US$6.29 | ||
FIG Figma -8.1%7D -38.6%3M | US$17.47 7.0% undervalued intrinsic discount | PS 8.6x | E 49.0% | US$40.25 | ||
FBR FBR -25.0%7D -25.0%3M | AU$0.003 97.0% undervalued intrinsic discount | PS 16.3x | S n/a | n/a |